PEPCID AC OTC
Generic Name and Formulations:
Famotidine 10mg tabs, gelcaps; 20mg tabs.
McNeil Consumer Healthcare
Indications for PEPCID AC:
Prevention and relief of heartburn, acid indigestion, sour stomach.
Take with water. 10–20mg once or twice daily as needed; max 40mg/day. Prevention: take 10–60 minutes before ingesting problematic food/drinks.
Renal dysfunction. Pregnancy (Cat.B). Nursing mothers: not recommended.
Do not use with other acid reducers (eg, H2 blockers, acid pump inhibitors). Calcium: reduces absorption of tetracyclines, possibly other drugs.
Tabs 10mg—6, 12, 18, 50, 60, 70, 90; Gelcaps 10mg—6, 30, 50, 60, 70, 90; Tabs 20mg—5, 25, 50, 75; EZ Chews—8, 25, 50; Complete—5, 15, 25, 50
Endocrinology Advisor Articles
- Efficacy and Safety of Alirocumab in Diabetes Mellitus
- Safety of DPP-IV Inhibitor, Cardiovascular Events After ACS in Type 2 Diabetes
- Adjunctive Metformin for Insulin Resistance in T1D: A Clinical Perspective
- Effect of Fructose, Allulose on Postprandial Glucose Regulation in Type 2 Diabetes
- Sex Hormone Levels May Affect Postmenopausal Heart Disease Risk
- Diabetes Treatments
- Metformin May Decrease Colorectal Cancer Risk Among Males With Diabetes
- SGLT2 Inhibitor, GLP-1 Receptor Agonist Combination Treatment for Type 2 Diabetes: Expert Insights
- Semaglutide May Induce Weight Loss in Type 2 Diabetes Despite BMI
- FDA Clears Omnipod DASH System for Diabetes Management
- Menopausal Hormone Therapy Slows Cognitive Decline in Postmenopausal Women
- Does Maintenance of Certification Status Affect Patient Care?
- Emotional Hyper-Reactivity and Cardiometabolic Risk in Remitted Bipolar Disorder
- Reduced Mortality for Women Undergoing Assisted Reproduction Likely Due to "Healthy Patient Effect"
- Romosozumab Followed by Denosumab Effective for BMD Increase in Postmenopausal Women